1-4 of 4
Martin Thelen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs but show increased T-cell activation

Jonas Lehmann, Martin Thelen, Christoph Kreer, Simon Schran, Maria A. García-Marquez, Igor Cisic, Klara Siepmann, Elena M. Hagen, Hans Nikolaus Caspar. Eckel, Philipp Lohneis, Stephan Kruger, Stefan Boeck, Steffen Ormanns, Martina Rudelius, Jens Werner, Felix Popp, Florian Klein, Michael S. von Bergwelt-Baildon, Christiane J. Bruns, Alexander Quaas, Kerstin Wennhold, Hans A. Schlößer
Journal: Cancer Immunology Research
Cancer Immunol Res (2024)
https://doi.org/10.1158/2326-6066.CIR-24-0299
Published: 11 December 2024
View article titled, Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs but show increased T-cell activation
Open the PDF for Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs but show increased T-cell activation in another window
Includes: Supplementary data
Journal Articles

CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses

Kerstin Wennhold, Martin Thelen, Jonas Lehmann, Simon Schran, Ella Preugszat, Maria Garcia-Marquez, Axel Lechner, Alexander Shimabukuro-Vornhagen, Meryem S. Ercanoglu, Florian Klein, Fabinshy Thangarajah, Sebastian Eidt, Heike Löser, Christiane Bruns, Alexander Quaas, Michael von Bergwelt-Baildon, Hans A. Schlößer
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (9): 1098–1108.
https://doi.org/10.1158/2326-6066.CIR-20-0949
Published: 01 September 2021
View article titled, CD86<sup>+</sup> Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
Open the PDF for CD86<sup>+</sup> Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses in another window
Includes: Supplementary data
Journal Articles

Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy

Kerstin Wennhold, Martin Thelen, Hans Anton Schlößer, Natalie Haustein, Sabrina Reuter, Maria Garcia-Marquez, Axel Lechner, Sebastian Kobold, Felicitas Rataj, Olaf Utermöhlen, Geothy Chakupurakal, Sebastian Theurich, Michael Hallek, Hinrich Abken, Alexander Shimabukuro-Vornhagen, Michael von Bergwelt-Baildon
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (9): 730–743.
https://doi.org/10.1158/2326-6066.CIR-16-0236
Published: 31 August 2017
View article titled, Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy
Open the PDF for Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma

Sebastian Theurich, Sacha I. Rothschild, Michael Hoffmann, Mario Fabri, Andrea Sommer, Maria Garcia-Marquez, Martin Thelen, Catherine Schill, Ramona Merki, Thomas Schmid, Dieter Koeberle, Alfred Zippelius, Christian Baues, Cornelia Mauch, Christian Tigges, Alexander Kreuter, Jan Borggrefe, Michael von Bergwelt-Baildon, Max Schlaak
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (9): 744–754.
https://doi.org/10.1158/2326-6066.CIR-15-0156
Published: 01 September 2016
View article titled, Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Open the PDF for Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma in another window